Tenet Healthcare (NYSE:THC) shares climbed 14.6% in premarket trading on Friday after the healthcare provider delivered stronger-than-expected second-quarter results and significantly increased its full-year outlook, reinforcing investor confidence despite recent concerns surrounding the hospital sector.
The Dallas-based operator outperformed Wall Street expectations on both earnings and revenue, prompting a sharp positive reaction from the market.
Quarterly results comfortably beat estimates
Tenet reported second-quarter earnings of $6.12 per share, well above analysts’ consensus estimate of $4.26 per share.
Revenue reached $5.63 billion, exceeding the expected $5.43 billion and reflecting solid operational performance across the company’s healthcare network.
The stronger-than-anticipated results stood out against a backdrop of cautious sentiment that has weighed on hospital operators in recent weeks.
Company raises full-year outlook
Alongside the quarterly report, Tenet substantially increased its financial guidance for 2026.
The company now expects full-year earnings per share to range between $20.30 and $21.69, comfortably ahead of the previous analyst consensus of $17.81.
Revenue guidance was also lifted to between $21.9 billion and $22.5 billion.
Management credited the improved outlook to healthy same-store revenue growth and disciplined cost management across both its Hospital Operations and Ambulatory Care businesses.
Financial strength continues to improve
The stronger earnings follow a recent credit rating upgrade from Moody’s, which highlighted the company’s ongoing debt reduction efforts and improving cash generation.
That upgrade had already pointed to strengthening financial fundamentals before the latest quarterly results were released.
Tenet distinguishes itself from sector peers
The results come at a time when investors have become increasingly cautious toward hospital operators.
Earlier in the earnings season, HCA Healthcare lowered its full-year profit outlook after reporting pressure from a less favourable payer mix as the number of uninsured patients increased.
That announcement weighed on the broader for-profit hospital sector, including Tenet shares.
However, Tenet’s latest performance suggests the company has been able to outperform many of its peers, supported by its diversified business model and the continued expansion of United Surgical Partners International, the largest ambulatory surgery network in the United States.
Strong earnings drive market re-rating
While the broader U.S. equity market posted modest gains, with the S&P 500, Dow Jones Industrial Average and Nasdaq all trading higher, Tenet’s double-digit advance reflected company-specific optimism rather than broader market momentum.
The combination of a substantial earnings beat, higher full-year guidance and evidence of resilient operating performance has prompted investors to reassess the company’s outlook.
Despite Friday’s rally, Tenet Healthcare shares, trading around $228.13, remain below their 52-week high of $247.21, leaving room for further valuation reassessment as the market absorbs the stronger earnings outlook.
Tenet Healthcare Corporation stock price
